  Acoustic AI

    technologies for

    better 

    sleep health

Clinically oriented

Innovation-driven

Science based

Research-driven

mehr zu unserer Technologie

ABOUT DIAMETOS

Digital innovations in medicine - from Potsdam

Diametos is a Potsdam-based digital health company that develops medical software solutions for analyzing the causes of snoring and assessing the risk of obstructive sleep apnea. The company's goal is to make the treatment of sleep-related breathing disorders more efficient and cost-effective through evidence-based, digital approaches.

TECHNOLOGY

Technology for clinically relevant and sustainable innovation

"Listen, analyze, deliver medical confidence"

Phenotyping of snoring

Hearing Sleep Apnea

Resource-saving algorithms

Medically validated technology

Mehr über unsere Technologie erfahren
→

RESEARCH

Where excellent science becomes innovation

Diametos is built on a strong scientific foundation of over 13 years of cutting-edge academic and clinical research. Our leadership team is closely connected with leaders in international sleep and audio research. In collaboration with renowned universities and world-renowned partners, we translate excellent science into solutions with real relevance.

MANAGEMENT

Scientific expertise meets entrepreneurial experience

Dr. Christoph Janott

Managing Director and Co-founder

Dr. Christoph Janott combines deeply rooted scientific expertise with many years of industry experience. For over a decade, he has conducted research at the interface of academic science and applied medical and audio innovation, initiating and overseeing significant interdisciplinary projects. At the same time, he has extensive experience in managing growing technology companies and is driving the strategic expansion of Diametos and its collaboration with international research and industry partners.

LinkedIn Profile

INVESTORS & FUNDING

Private investment and public funding – a strong foundation for innovation

The establishment and development of Diametos were made possible by venture capital from experienced business angels and international industry partners. In addition, research funding from the Investment Bank of the State of Brandenburg (ILB) significantly contributed to establishing the company's scientific and technological foundation.

Diametos is funded by the European Union and the state of Brandenburg.

Learn more

A FUTURE-OF-CARE MODEL

Reduce healthcare costs, improve quality of life.

Current data demonstrate the medical and health economic benefits of digital sleep apnea early detection.

A health economic Markov model based on peer-reviewed clinical data demonstrates the positive effects of early OSA screening.

Braun et. al., Cost-Effectiveness of Smartphone-Based Screening for Obstructive Sleep Apnea: A Markov Model Analysis From the German Statutory Health Insurance Perspective, Value in Health, Vol 28, No 12, Supplement 1, 2025, pp. S156-S157, 2025

Positive effects of systematic, easy-to-access sleep apnea screening

        Reduction of direct healthcare costs per patient
      
17 %

        Improvement in health-related quality of life (QALYs)
      
20 %

        Reduction of clinically relevant events
      
17–32 %

      All data calculated over a ten-year horizon.

CONTACT

Location

Diametos GmbH
Opolestraße 2, 14469 Potsdam
Germany

E-mail

Phone

+49 (0)331 23189070

Acoustic AI technologies for better sleep health